An invalid vocabulary is selected. Please change it in the options.
Titlesort descending Credits Start date - Expiration date
NCCN Guidelines® Updates: New Immunotherapy Strategies for Improving Outcomes in Non-Small Cell Lung Cancer 1.00 05/15/2019 - 12:00am to 03/01/2020 - 12:00am
NCCN Guidelines® Updates: Treatment of Pancreatic Cancer 0.56 05/15/2019 - 12:00am to 03/01/2020 - 12:00am
NCCN Harmonized Guidelines™ for Sub-Saharan Africa 0.75 05/15/2019 - 12:00am to 03/01/2020 - 12:00am
NCCN Oncology Case Manager and Medical Director Program: Management of Pediatric Patients with Cancer 1.25 09/24/2019 - 12:00am to 01/19/2020 - 12:00am
NCCN Oncology Case Manager and Medical Director Program: Managing Cancer Pain in the U.S. Opioid Crisis 1.25 09/03/2019 - 12:00am to 02/28/2020 - 12:00am
NCCN Oncology Case Manager and Medical Director Program: New Treatments for Metastatic Lung Cancer 1.25 09/03/2019 - 12:00am to 02/28/2020 - 12:00am
NCCN Oncology Case Manager and Medical Director Program: Supportive Care of Hematopoietic Cell Transplant Patients 1.25 10/14/2019 - 12:00am to 01/26/2020 - 12:00am
NCCN Oncology Case Manager and Medical Director Program: Updates in the Treatment of Follicular Lymphoma and Diffuse Large B-Cell Lymphomas 1.25 09/03/2019 - 12:00am to 01/06/2020 - 12:00am
NCCN Oncology Case Manager and Medical Director Program: Updates in the Treatment of HER-2 Positive Breast Cancer 1.25 09/03/2019 - 12:00am to 12/23/2019 - 12:00am
Neoadjuvant and Adjuvant Therapies for Early Stage Breast Cancer, Including SABCS Updates 0.84 03/18/2019 - 12:00am to 03/18/2020 - 12:00am
New Biosimilar Approvals for Myeloid Growth Factors and Anemia 0.75 05/15/2019 - 12:00am to 03/01/2020 - 12:00am
New Systemic Therapies for Metastatic Breast Cancer, Including SABCS Updates 0.85 03/18/2019 - 12:00am to 03/18/2020 - 12:00am
New Therapies for Ovarian Cancer 0.53 05/15/2019 - 12:00am to 03/01/2020 - 12:00am
Novel Treatment Options for Neuroendocrine Tumors 0.75 05/15/2019 - 12:00am to 03/01/2020 - 12:00am
Optimizing Small Molecule Inhibitor Therapy for Relapsed/Refractory B-cell Lymphomas 1.00 11/01/2018 - 12:00am to 11/01/2019 - 12:00am

Pages